Showing results (181-190 of 514) with videos related to
Sort By:
Pageof 52
Crohn'S & Colitis 360|February 13, 2023
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab ReintroductionInessa Normatov, Daniela Fluxa, Jingzhou D Wang, et al.Crohn'S & Colitis 360|February 13, 2023
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic ColitisThomas W Fredrick, Guilherme P Ramos, Manuel B Braga Neto, et al.Crohn'S & Colitis 360|February 13, 2023
Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's DiseaseScott David Lee, Kendra Kamp, Kindra Dawn Clark-SnustadCrohn'S & Colitis 360|February 13, 2023
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's DiseaseBruce R Yacyshyn, Stephen Hanauer, Preston Klassen, et al.Crohn'S & Colitis 360|February 13, 2023
Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative ColitisSatohiro Matsumoto, Hirosato MashimaCrohn'S & Colitis 360|February 13, 2023
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative AnalysisDavid T Rubin, Laurent Peyrin-Biroulet, Walter Reinisch, et al.Crohn'S & Colitis 360|February 13, 2023
Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018Aman S Bali, Michael F Picco, Jana G Hashash, et al.Crohn'S & Colitis 360|February 13, 2023
Hemolytic Anemia in Inflammatory Bowel Disease: Our "Gut" Tells Us to Blame the DrugMatthew Berger, Maisa Abdalla, Arthur DeCrossCrohn'S & Colitis 360|February 13, 2023
Persistence, Dosing, and Other Treatment Patterns Among Crohn's Disease Patients Initiating Biologics in United StatesAmanda Teeple, Janvi Sah, Rajesh Mallampati, et al.Crohn'S & Colitis 360|February 13, 2023
Adalimumab, Infliximab, and Vedolizumab in Treatment of Ulcerative Colitis: A Long-Term Retrospective Study in a Tertiary Referral CenterAnn-Lorie Gagnon, William Beauchesne, Laurence Tessier, et al.Pageof 52